
Designation: Senior Scientist
Job Location: BBRC (S11), Syngene International Ltd., Bangalore, India
Department: Biopharmaceutics (BPH)
Position Level: Level 7 (Core)
Job Purpose: To conduct and assist in pre-formulation and phase-appropriate formulation development activities to support pre-clinical and clinical studies.
About Syngene
Incorporated in 1993, Syngene International Ltd. is an innovation-focused global discovery, development and manufacturing organization providing integrated scientific services to the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries around the world. Syngene’ s clientele includes world leaders such as Bristol-Myers Squibb, Baxter, Amgen, GSK, Merck KGaA and Herbalife. Its innovative culture is driven by the passion of its 4240 – strong team of scientists who work with clients from around the world to solve their scientific problems, improve R&D productivity, speed up time to market and lower the cost of innovation.
Educational Qualifications & Experience:
M. Pharm or M.S. in Pharmaceutics/ Pharmaceutical chemistry with 0 – 2 years of relevant industrial experience, preferably in Pharmaceutical Sciences.
Understanding of Physicochemical Properties, Pre-formulation, Formulation Development, Formulation Stability Studies, Analytical Chemistry, Solid State Characterization, Data Interpretation.
Team Player, Ready to Learn, Cross-Functional Collaboration, Good Writing, Communication and Presentation skills
Interfaces & Dependencies:
Internal - Candidate will be interacting with PK/ PD/ toxicology, medicinal chemistry and analytical R&D groups
External - Candidate will have occasional interactions with Syngene’ clients working in discovery and development pharmaceutics.
It is the policy of Syngene to provide equal employment opportunity (EEO) to all persons regardless of age, color, national origin, citizenship status, physical or mental disability, race, religion, creed, gender, sex, sexual orientation, gender identity and/or expression, genetic information, marital status, status with regard to public assistance, veteran status, or any other characteristic protected by applicable legislation or local law. In addition, Syngene will provide reasonable accommodation for qualified individuals with disabilities.

Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022) is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors.
Syngene's more than 6000 scientists offer both skills and the capacity to deliver great science, robust data security, and quality manufacturing, at speed, to improve time-to-market and lower the cost of innovation.
With a combination of dedicated research facilities for Amgen, Baxter, and Bristol-Myers Squibb as well as 2 Mn sq. ft of specialist discovery, development and manufacturing facilities, Syngene works with biotech companies pursuing leading-edge science as well as multinationals, including GSK, Zoetis and Merck KGaA.
For more details, visit www.syngeneintl.com or write to us at bdc@syngeneintl.com